BackEnanta Pharmaceuticals Overview
Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals Target Price

Where could ENTA trade next? Consensus target price: $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.5

Average Target Price

$20.0048.1% upside

1 analysts in the last 4 months

High: $20 | Low: $20

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-23H.C. WainwrightBrandon Folkes$2048.1% upsideOpen
2025-10-01JefferiesAkash Tewari$2048.1% upsideOpen
2025-06-03JMP SecuritiesRoy Buchanan$2477.8% upsideOpen
2022-12-09H.C. Wainwright$56314.8% upsideOpen
2022-11-22RBC Capital$54300% upsideOpen
2022-07-29Piper SandlerYasmeen Rahimi$87544.4% upsideOpen

Enanta Pharmaceuticals (ENTA) FAQ

Enanta Pharmaceuticals (ENTA) currently reports a target price of $20. Use the charts on this page to explore Enanta Pharmaceuticals's target price history and peer comparisons.

Analysts' average 12-month price target for Enanta Pharmaceuticals is $20, about 48.1% upside from the current share price of $13.5. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $20, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enanta Pharmaceuticals, and consider following ENTA for alerts when major investors trade the stock.

Enanta Pharmaceuticals is classified in the Healthcare sector. On target price, it currently shows $20. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENTA with unrelated industries.